nimotuzumab
biocon,oncoscience,daiichi sankyo
['nimotuzumab', 'pancreatic', 'jw']
nimotuzumab added to gemcitabine extends os and pfs in patients with kras wild-type advanced or metastatic pancreatic cancer, per data presented at #asco22. article for by : 
Editor for @PatientPower and @OBRtweets | she/her